Intratumor heterogeneity and evolutionary bottlenecking. These are the cancer stem cell model and the clonal evolution model. Clinical applications and limitations of next generation. In both studies, somatic alterations in the brain metastases were frequently discordant with those in the primary tumor, suggesting divergent evolution at metastatic sites and raising questions about the use of biomarkers in patients in clinical trials with targeted therapies. Heterogeneity is a hallmark of tumors and has a crucial role in the outcome of the malignancy, because it not only confounds diagnosis, but also challenges the design of effective therapies. Reliability of wholeexome sequencing for assessing. Intratumor heterogeneity may contribute to this failure by initiating phenotypic diversity enabling drug resistance to emerge and by introducing tumor sampling bias. Through the analysis of structural variations and allelic frequencies in a primary basal breast cancer, a xenograft, and a brain metastasis from the same patient, ding and colleagues showed that the metastasis may derive from a lowfrequency subclone within the primary. This intratumor heterogeneity will have clinical implications and it is.
Intratumor heterogeneity in localized lung adenocarcinomas. Aug 27, 2014 deciphering genetic intratumor heterogeneity can reveal the temporal composition of genetic events that take place during the disease course. Jan 09, 2019 intratumor heterogeneity analysis by multiregion tissue sequencing. Pancancer analysis of the extent and consequences of.
Apr 01, 2014 reports of clonal heterogeneity in this disease challenge the concept of targeted monotherapy, yet a small subset of patients derives extended benefit. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. In recent years, it has become evident that intratumor heterogeneity of breast cancer is a big challenge. The phylogenetic tree was constructed with all somatic mutations. Genomic studies in breast, liver, pancreas, and kidney tumors have revealed regionally diverse mutational landscapes in primary tumors as well as metastatic sites and sites of local recurrence after treatment 5 8. Intratumor heterogeneity could inform the use and type of. Radiogenomics analysis of intratumor heterogeneity in a. Heterogeneity is an important attribute of cancer and a major contributor to tumor progression.
While intertumor heterogeneity has been studied widely, intratumor heterogeneity has been neglected even though numerous. Genomic and tcr repertoire intratumor heterogeneity of smallcell lung cancer. Yap ta, gerlinger m, futreal pa, pusztai l, swanton c. Biological and therapeutic impact of intratumor heterogeneity in. Accumulating evidence suggests that intratumor heterogeneity likely is the key to understanding treatment failure. A the development of intratumor heterogeneity is analogous to a growing tree. Envisaging tumor growth as a darwinian tree with the trunk representing ubiquitous mutations and the branches representing heterogeneous mutations may help in drug discovery and. Evolution of genomic and tcell repertoire heterogeneity of. Intratumor heterogeneity may contribute to this failure by initiating phenotypic diversity enabling drug resistance to emerge and by introducing tumor sam intratumor heterogeneity.
Tumour heterogeneity describes the observation that different tumour cells can show distinct morphological and phenotypic profiles, including cellular morphology, gene expression, metabolism, motility, proliferation, and metastatic potential. Comprehensive sampling techniques and measuring heterogeneity. Intratumoral heterogeneity, its contribution to therapy. Assessment of multiple tumour regions and tracking of changes occurring over time may be necessary to define optimal treatment approaches for individual patients. One potential mechanism underlying therapeutic resistance may be intratumor heterogeneity ith, making mpm challenging to eradicate. Perspective cancer prevention research the origins and. The significance of intertumor and intratumor heterogeneity. For example, one component of the breast cancer scarffbloomrichardson grading system comprises an assessment of nuclear pleo. Pdf genomic and tcr repertoire intratumor heterogeneity.
Few chemotherapeutics provide any improvement in outcome, and even then, for approved therapies, the survival benefits are marginal. Intratumor heterogeneity of homologous recombination. Tumor heterogeneity a contemporary concept founded on historical insights and predictions. Envisaging tumor growth as a darwinian tree with the trunk representing ubiquitous mutations and the branches representing heterogeneous. Multiple region wholeexome sequencing reveals dramatically. Mar 24, 2014 understanding intratumoural heterogeneity is essential for designing effective therapeutic strategies in the context of precision medicine. Branched tree evolution model glioblastoma multiforme.
Finally, we outline potential strategies to improve therapeutic outcomes by directly targeting intratumor heterogeneity. We here discuss how it can be applied to a cancer cell population, in which there is an increasing interest in genetic variation within a tumor. Biological significance of tumor heterogeneity in esophageal. Clear cell renal carcinomas ccrccs can display intratumor heterogeneity ith. Tumor heterogeneity and the biology of cancer invasion and metastasis. Despite multimodality therapy, the majority of mpms recur and eventually become refractory to any systemic treatment.
Research article genomic and tcr repertoire intratumor. A look inside its heterqenaus nature intratumor heterogeneity. Intratumor heterogeneity comparison among different. Although aggressive minimum depth filtering would not improve the false detection rate of subclonal mutations, excluding mutations in lowmappability regions or in certain mutational contexts could help. Kif5bret fusions in chinese patients with nonsmall cell lung cancer cancer 119. Tumor heterogeneity has been found in virtually all types of cancer, and can be broadly divided into interpatient and intrapatient heterogeneity. Seeing the wood for the trees on publons download web of science my research assistant. Intratumoral heterogeneity of alkrearranged and alkegfr.
Tumor genetic analyses of patients with metastatic renal. The concept of tumor heterogeneity contains both intertumor and intratumor forms. One important concept about intratumor genomic heterogeneity is the genomeaxis evolution model, which describes that gene evolution can increase the survival. Intratumor heterogeneity represents integration of inputs from genetic, phenotypic, and microenvironmental heterogeneity, in turn increasing the odds of both preexistence of tolerant and resistant subpopulations, and the ability to evolve new adaptations. Crick researchers are working at the forefront of the scientific response to answer some of the most urgent questions about the sarscov2 pathogen, from how we can improve testing, to why its deadly in some people but causes no symptoms in others. Intratumor heterogeneity in human glioblastoma reflects. Futreal pa, gerliner m, pusztai l, swanton c, yap ta.
There are two models used to explain the heterogeneity of tumour cells. On average, 76% of all mutations and 20 out of 21 known cancer gene. When analyzing genomesequencing data derived from singletumor samples, it is important to recognize that, technically, sequences obtained from. Intratumor heterogeneity illuminates a tumors life history. The goal of this study is to assess the consistency of these hrd measures in different biopsies from distinct areas.
Tumor evolution as a therapeutic target cancer discovery. There is an increasing interest in such genetic variation within a tumor, or ith intratumor heterogeneity. Aug 28, 2015 ta yap, m gerlinger, pa futreal, etal. The 3biomarker homologous recombination deficiency hrd assay measures the number of telomeric allelic imbalances, loss of heterozygosity, and largescale state transitions in tumor dna and combines these metrics into a single score that reflects dna repair deficiency. This intratumor heterogeneity provides the fuel for the engine of natural selection that drives the processes of carcinogenesis and acquired therapeutic resistance in neoplasms. Intertumor heterogeneity concerns the phenotypic and molecular differences among tumors from different patients, while intratumor heterogeneity refers to biological variations within the same tumor 9,10,11,12. There is a growing evidence of intratumor heterogeneity in different types of cancers including breast cancer 19, renal carcinomas 20, 21, and glioblastomas 22.
Acquired resistance is the direct consequence of preexisting intratumor heterogeneity and ongoing diversification during therapy, which enables some tumor cells to survive treatment and facilitates the development of new therapyresistant phenotypes. Neutral theory in cancer cell population genetics molecular. Seeing the wood for the trees clonal evolution in cancer c. Such variations produce a tumor that consists of heterogeneous subclones rather than a single type of homogeneous clonal cells marusyk et al. Bring the power of the web of science to your mobile device, wherever inspiration strikes. The team noted a wide range of allelic variant frequencies in the. Mar 28, 2012 intratumor heterogeneity may contribute to this failure by initiating phenotypic diversity enabling drug resistance to emerge and by introducing tumor sampling bias.
British journal of cancer advance online publication, 8 january. Because higher mutant allele tumor heterogeneity math. The origins of intratumor heterogeneity have been the subject of much discussion 6, 7. A substantial obstacle to appropriate selection of precision therapies is intratumor genetic heterogeneity. Moreover, we also suggest the key goals whose achieve ment promises to minimize the problem of intratumor heterogeneity and to identify new prognostic, predictive, and target markers for adequate and effective treatment of cancer. Therefore, one measure of the degree of intratumor heterogeneity is the heterogeneity rate and it is defined as the number of mutated genes that are detected in one or more, but not all regions of a tumor. This phenomenon occurs both between tumours intertumour heterogeneity and within tumours intratumour heterogeneity. The challenge of intratumour heterogeneity in precision. Sep 01, 2014 evidence of intratumor genetic heterogeneity was, however, observed, given that the liver metastasis was enriched for mutations either only present at low allele fractions in the primary tumor i. Recent technological advances in the field of molecular diagnostics including bloodbased tumor genotyping allow the measurement of clonal evolution in patients with cancer, thus adding a new dimension to precision medicine. Cancer is a disease of genomic alterations and, based on the nccn clinical practice guidelines in oncology nccn guidelines, the use of therapeutic agents that target specific genomic alterations is standard of care for several tumor types, including lung and breast carcinomas. The trunk harbors the founding ubiquitous driver mutations of a. The impact of genetic heterogeneity on biomarker development.
Surgery remains the only chance of cure, yet only 20% of patients will be alive at 5 years after pancreatic resection. Ta yap, m gerlinger, pa futreal, l pusztai, c swanton. Deciphering intratumor heterogeneity and temporal acquisition. Deciphering intratumor heterogeneity and temporal acquisition of. We applied multiregion wholeexome sequencing wes on 11 localized lung adenocarcinomas. Tumor heterogeneitybladder cancerpersonalized medicinetherapy. Tumor genetic analyses of patients with metastatic renal cell. This intratumor heterogeneity impedes the investigation and treatment of cancer because individual tumortissue samples may not be representative of the whole tumor, and predictions about its evolution frequently are inaccurate. Malignant pleural mesothelioma mpm is considered an orphan disease with few treatment options. Mar 05, 20 glioblastoma gb is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Mechanisms underlying intratumor heterogeneity can be broadly.
Both patients have similar average intratumor heterogeneity rates of approximately 90% for mutated genes with either spms or indels. Tumor microenvironment tme consists of heterogeneous number and types of. Kimuras neutral theory provides the whole theoretical basis of the behavior of mutations in a wrightfisher population. Most advanced solid tumors remain incurable, with resistance to chemotherapeutics and targeted therapies a common cause of poor clinical. The models are not mutually exclusive, and it is believed that they both contribute to heterogeneity in varying amounts across different tumour types. The translation of this new knowledge into clinical benefit implies rethinking therapeutic strategies. New clinical trial designs in the era of precision. Apr 28, 2016 yap ta, gerlinger m, futreal pa, pusztai l, swanton c 2012 intratumor heterogeneity.
A new vision for an old problem tumor morphologic heterogeneity has long been recognized by pathologists and forms the basis of many tumor grading prognostic classi. However, the extent of intratumor heterogeneity as a result of tumor evolution is still poorly understood. Pancreatic cancer has become the third leading cause of cancerrelated death, with little improvement in outcomes despite decades of research. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma. Analysis of intratumor heterogeneity unravels lung cancer. Intratumour heterogeneity in renal, prostate, and bladder cancers challenges personalised cancer medicine approaches. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm suspicious for a follicular neoplasm cytology by thyroseq v2 nextgeneration sequencing. Intratumor heterogeneity of homologous recombination deficiency. Intratumor heterogeneity manifests in spatial and temporal patterns of genetic, phenotypic, and functional diversity. Identification of a therapeutic strategy targeting amplified fgf19 in liver cancer by oncogenomic screening. Bioinformatics tools such as absolute and pyclone integrate data on variant allele frequency, local copy number and tumor purity, and can give estimates of the clonality of somatic events, even within individual tumor biopsies.
There is a growing evidence of intratumor heterogeneity in different types of cancers including breast cancer, renal carcinomas 20, 21, and glioblastomas. Modulating secreted components of tumor microenvironment. The challenges of tumor genetic diversity mroz 2017. Deciphering intratumor heterogeneity using cancer genome.
608 64 1528 1698 1683 1701 611 308 1409 1700 885 879 805 816 31 1012 904 355 1209 281 786 264